Effects of the specific angiotensin II receptor antagonist losartan on urate homeostasis and intestinal urate transport

Journal of Pharmacology and Experimental Therapeutics

Volumn 276, Issue 1, 1996, Pages 187-193

  Hatch, Marguerite ^a   Freel, Robert W ^a   Shahinfar, S ^b   Vaziri, N D ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b MERCK RESEARCH LABORATORIES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2 BUTYL 4 CHLORO 1 [[2' (1H TETRAZOL 5 YL) 4 BIPHENYLYL]METHYL] 5 IMIDAZOLECARBOXYLIC ACID; ALLOPURINOL; ANGIOTENSIN RECEPTOR ANTAGONIST; ANGIOTENSINAMIDE; ANTIHYPERTENSIVE AGENT; CHLORIDE ION; CREATININE; DRUG METABOLITE; LOSARTAN; OXONIC ACID; URATE OXIDASE; URIC ACID; URICOSURIC AGENT; XANTHINE OXIDASE;

ANIMAL MODEL; ANIMAL TISSUE; ANTIHYPERTENSIVE THERAPY; ARTICLE; CHLORIDE TRANSPORT; CHRONIC KIDNEY FAILURE; CONTROLLED STUDY; DRUG EFFECT; HYPERTENSION; HYPERURICEMIA; HYPERURICOSURIA; HYPOURICEMIA; INTESTINE ABSORPTION; INTRAPERITONEAL DRUG ADMINISTRATION; KIDNEY CLEARANCE; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; URIC ACID BLOOD LEVEL;

ANGIOTENSIN II; ANIMALS; ANTIHYPERTENSIVE AGENTS; BIOLOGICAL TRANSPORT; BIPHENYL COMPOUNDS; CHLORIDES; COLON; HOMEOSTASIS; IMIDAZOLES; INTESTINAL ABSORPTION; KIDNEY; KIDNEY FAILURE, CHRONIC; LOSARTAN; MALE; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, ANGIOTENSIN; SENSITIVITY AND SPECIFICITY; TETRAZOLES; URATE OXIDASE; URIC ACID; XANTHINE OXIDASE;

EID: 0029988760     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. BINDER, H. J. AND SANDLE, G. I.: Electrolyte absorption and secretion in the mammalian colon. In Physiology of the Gastrointestinal Tract, ed. by L. E. Johnson, Raven Press, New York, 1987.
2. BRECKENRIDGE, A.: Hypertension and hyperuricemia. Lancet 1: 15-18, 1966.
3. BURNIER, M., HAGMAN, M., NUSSBERGER, J., BIOLLAZ, J. ARMAGNAC, C , BROUARD, R., WAEBER, B. AND BRUNNER, H. R.: Short-term and sustained renal effects of angiotensin II receptor blockade in healthy subjects. Hypertension. 25: 602-609, 1995.
4. BURNIER, M., RUTSCHMANN, B , NUSSBERGER, J., VERSAGGI, J., SHAHINFAR, S., WAEBER, B. AND BRUNNER, H. R : Salt-dependent renal effects of an angiotensin II antagonist in healthy subjects. Hypertension. 22: 339-347, 1993.
5. CANNON, P. J., STASON, W. B., DEMARTINI, F. E., SOMMERS, S. C. AND LARAGH, J. H : Hyperuricemia in primary and renal hypertension. N. Engl. J. Med. 275: 457-464, 1966.
6. COX, H. M., CUTHBERT, A. W. AND MUNDAY, K. A.: The effect of angiotensin II upon electrogenic ion transport in rat intestinal epithelia. Br. J. Pharmacol. 90: 393-401, 1987.
7. COX, H. M., MUNDAY, K. A. AND POAT, J. A.: Identification of selective, high affinity (I)-angiotensin and (I)-bradykinin binding sites in rat intestinal epithelia. Br. J. Pharmacol. 87: 201-209, 1986.
8. DAVIES, N. T., MUNDAY, K. A. AND PARSONS, B. J.: The effect of angiotensin on rat intestine fluid transfer. J. Endocrinol. 48: 39-46, 1970.
9. DUGGAN, K. A., MENDELSOHN, F. A. O. AND LEVENS, N. R.: Angiotensin receptors and angiotensin I-converting enzyme in rat intestine. Am. J. Physiol 257: G504-G510, 1989.
10. HATCH, M., FREEL, R. W. AND VAZIRI, N. D.: Mechanisms of oxalate absorption and secretion across the rabbit distal colon. Pflugers Arch. 426: 101-109, 1994.
11. HATCH, M. AND VAZIRI, N. D.: Enhanced enteric excretion of urate in rats with chronic renal failure. Clin Sci 86: 511-516, 1994
12. HORNYCH, A., MEYER, P. AND MILLIEZ, P.: Angiotensin, vasopressin, and cyclic AMP: Effects on sodium and water fluxes in rat colon. Am. J. Physiol. 224: 1223-1229, 1973.
13. LEVENS, N. R.: Control of intestinal absorption by the renin-angiotensin system. Am. J. Physiol. 249: G3-G15, 1986.
14. LEVENS, N. R., PEACH, M J., CAREY, R. M., POAT, J. A. AND MUNDAY, K. A.. Changes in an electroneutral transport process mediated by angiotensin II in the rat distal colon. Endocrinology 108: 1497-1504, 1981a.
15. LEVENS, N. R., PEACH, M. J., CAREY, R M., POAT, J. A. AND MUNDAY, K. A : Response of rat jejunum to angiotensin II: Role of norepinephrine and prostaglandins. Am. J. Physiol. 240: G17-G24, 1981b.
16. NAKASHIMA, M., UEMATSU, T., KOSUGE, K. AND KANAMARU, M.: Pilot study of the uricosuric effect of DUP-753, a new angiotensin II receptor antagonist, in healthy subjects. Eur. J. Clin. Pharmacol. 42: 333-335, 1992.
17. SECHI, L. A., VALENTIN, J.-P., GRIFFIN, C. A. AND SCHAMBELIN, M.: Autoradiographic characterization of angiotensin II receptor subtypes in rat intestine. Am. J. Physiol. 265: G21-G27, 1993.
18. SMITH, R. D. AND BROWN, K. D.: Characterization and regulation of angiotensin receptors in rat intestinal epithelial cell line. Biochem. Soc. Trans. 19:440S, 1991.
19. TAMAOKI, J., KAZUO, I., CHIYOTANI, A., KONDO, M. AND KONNO, K: Angiotensin II-1 receptor mediated Cl secretion by canine tracheal epithelium. Am. Rev. Respir. Dis. 146: 1187-1191, 1992.
20. WONG, P. C., PRICE, W. A., CHIU, A. T., DÜNCIA, J. V., CARINI, R. R , WEXLER, R. R., JOHNSON, A. L. AND TIMMERMANS, P. B. M. W. M.: Nonpeptide angiotensin II receptor antagonists. IX. Antihypertensive activity in rats of DuP 753, an orally active antihypertensive agent. J. Pharmacol. Exp. Ther. 252:726-732, 1990.
21. XIE, M.-H., LIU, F.-Y., WONO, P. C., TIMMERMANS, P. B. M. W. M. AND COGAN, M G.: Proximal nephron and renal effects of DuP-753, a nonpeptide angiotensin II receptor antagonist. Kidney Int. 38: 473-479, 1990.